Cure8

Why This Matters

People labelled with IBS-D may actually have treatable organic conditions that require different tests and treatments; avoiding diagnostic mistakes can speed appropriate care and reduce unnecessary symptom-focused treatments.

Clinicians following guideline-recommended testing and monitoring can reduce missed diagnoses like microscopic colitis, bile acid diarrhoea, coeliac disease, and early IBD.

Who Should Pay Attention

Clinicians (gastroenterologists, primary care), researchers on diarrhoeal disorders, adult patients with IBS-D or persistent diarrhoea, and caregivers.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This narrative review summarizes common diagnostic and management errors in patients evaluated for diarrhoea-predominant irritable bowel syndrome (IBS-D) and conditions that mimic it (for example microscopic colitis, bile acid diarrhoea, small intestinal bacterial overgrowth, coeliac disease, exocrine pancreatic insufficiency, early IBD).

It draws on guideline recommendations and a broad literature base (RCTs, meta-analyses, systematic reviews) through 2025 and focuses on lapses in clinical reasoning and guideline adherence that lead to delayed or inappropriate care.

Key points in the review include the importance of considering and testing for common organic mimics rather than assuming functional IBS-D, following guideline-recommended testing (stool, blood, fecal calprotectin, serology, and colonoscopy with biopsy when indicated), and monitoring treatment response and diagnostic uncertainty rather than relying solely on symptom-based management.

The tone is clinical and practice-focused: the article is intended to help clinicians and informed patients recognize when further testing is warranted and avoid common pitfalls.

Keep In Mind

This entry is based on the PubMed abstract (narrative review, Current Medical Research and Opinion). The review synthesizes literature up to 2025 and guideline statements; it is not a new clinical trial. For specific diagnostic algorithms, consult full guidelines (ACG, AGA, BSG, ECCO) and the full article.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationCurrent medical research and opinion
AuthorsPavithra Senadheera, Bhagya Silva, Hiruni Jayasena +1 more
InstitutionFaculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Study typeJournal article, review
Indexed viaPubMed
Source typeResearch paper
PublishedAug 13, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →